New Deal Advisors supports Neo Apotek in sale to Dr. Max Group.
Milan, Nov. 20, 2023 – New Deal Advisors, an independent firm specializing in advisory services to M&A Transactions has supported Neo Apotek in its sale to Dr. Max Group.
Dr. Max Group, one of the most important operators specializing in pharmacy management in Europe, announces the acquisition of Neo Apotek S.p.A. in Italy. The operation brings the total number of pharmacies owned by Dr. Max in Italy to over 210 and makes it one of the main operators in the sector and consolidates its leadership position on the Italian market.
Neo Apotek S.p.A. is an important company in the Italian market which over the years has invested heavily in the growth and centrality of the figure of the pharmacist: the entry of over 130 pharmacies increases Dr. Max’s capillarity throughout the territory, with a notable impact on both in tourist locations and in metropolitan cities, in particular Milan, Venice, Verona, Bergamo and Turin.
New Deal Advisors with a team led by Antonio Ficetti Gasco (Partner), has provided Financial Due Diligence services to Neo Apotek and its shareholders, Route Capital.
***
New Deal Advisors is an independent firm specialising in advisory services in M&A. Established in 2012, New Deal Advisors provides support in a broad variety of extraordinary transactions streams including mergers and acquisitions, restructuring,
transformation processes, forensic and litigation activities, fairness opinions and valuation services. New Deal Advisors has worked for more than a decade alongside private equity funds, investment holdings, family offices, financial institutions and strategic players achieving to date the finalisation of over 200 deals.